SCHEMBL28690545

SCHEMBL28690545

CC(=O)N1CCN(c2cccc(Nc3ncc4cccc(-c5ccc(S(=O)(=O)NCC#N)cc5)c4n3)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.54
▸ CCNT1 O60563 9/20 0.50
▸ CCNA2 P20248 9/20 0.50
▸ CDK2 P24941 9/20 0.50
▸ CDK9 P50750 9/20 0.50
▸ CDK1 P06493 5/20 0.50
▸ CCNB1 P14635 5/20 0.50
▸ CDK7 P50613 4/20 0.50
▸ CCNH P51946 4/20 0.50
▸ CCNA1 P78396 3/20 0.50
▸ JAK2 O60674 5/20 0.48
▸ JAK3 P52333 3/20 0.48
▸ JAK1 P23458 1/20 0.48
▸ BRD4 O60885 3/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ SYK P43405 2/20 0.46
▸ FGFR2 P21802 1/20 0.44
▸ PTK2 Q05397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18376761 0.93 EGFR (0.52) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376831 0.92 EGFR (0.56) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376835 0.89 EGFR (0.58) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376829 0.87 EGFR (0.60) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376832 0.87 JAK2 (0.58) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376833 0.87 EGFR (0.56) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376747 0.85 EGFR (0.59) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376244 0.84 JAK2 (0.52) EGFRJAK2JAK3JAK1BRD4
SCHEMBL29368834 0.84 EGFR (0.62) EGFRCCNT1CCNA2CDK2CDK9
SCHEMBL18376840 0.84 EGFR (0.62) EGFRCCNT1CCNA2CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
Send feedback